Celltrion, Inc. (KRX:068270)
170,800
+2,300 (1.36%)
At close: Sep 19, 2025
Celltrion Market Cap
Celltrion has a market cap or net worth of 37.63 trillion as of September 19, 2025. Its market cap has decreased by -9.96% in one year.
Market Cap
37.63T
Enterprise Value
39.49T
Revenue
3.75T
Ranking
n/a
PE Ratio
77.66
Stock Price
170,800.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 37.63T, an increase of 36,148.05%. That is a compound annual growth rate of 41.16%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 37.63T | -6.79% |
Dec 30, 2024 | 40.37T | 44.32% |
Dec 28, 2023 | 27.97T | 21.61% |
Dec 29, 2022 | 23.00T | -16.64% |
Dec 30, 2021 | 27.59T | -43.68% |
Dec 30, 2020 | 48.99T | 102.64% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 72.88T |
ALTEOGEN | 25.25T |
SK Biopharmaceuticals | 8,888.55B |
Yuhan | 8,872.07B |
Peptron | 6,750.37B |
PharmaResearch | 6,202.62B |
ABL Bio | 5,910.48B |
LigaChem Biosciences | 5,585.58B |